文献速递支持与姑息治疗

2026年美国西班牙裔/拉丁裔人群癌症统计

Cancer statistics for Hispanic/Latino people, 2026.
PubMed 文献 · CA Cancer J Clin · 2026-01-01

美国癌症协会基于联邦资助的癌症登记、生命统计和调查数据,报告2026年美国西班牙裔/拉丁裔人群的癌症发生、危险因素和筛查情况。预计2026年该人群新发癌症229,900例、死亡54,200例;1998-2022年女性发病率上升而男性下降,男女发病率比从2002年峰值1.40降至2022年1.01。

要点

  • 2026年预计西班牙裔/拉丁裔新发癌症229,900例,死亡54,200例。
  • 1998-2022年女性癌症发病率从345升至385/10万,男性从471降至389/10万。
  • 西班牙裔人群肝癌、胃癌、胆囊癌发病率是白人的两倍,宫颈癌筛查率低11个百分点。

核心结论

  • 西班牙裔/拉丁裔人群癌症谱独特,预防应针对感染防控、健康饮食、体力活动和常规筛查。

研究设计与样本

  • 美国癌症协会基于联邦资助的高质量人群癌症登记数据、国家生命统计和调查数据进行的描述性统计分析。

主要发现

  • 2026年预计美国大陆和夏威夷西班牙裔/拉丁裔新发癌症229,900例,死亡54,200例。
  • 1998-2022年西班牙裔女性癌症发病率从345/10万升至385/10万,男性从471/10万降至389/10万。
  • 男女发病率比从2002年峰值1.40(95% CI, 1.38-1.42)降至2022年1.01(95% CI, 1.00-1.02; p = .02)。
  • 与白人相比,西班牙裔人群肺癌和膀胱癌发病率减半,乳腺癌低24%,但肝癌、胃癌和胆囊癌发病率翻倍,急性淋巴细胞白血病高61%-65%,宫颈癌高36%。
  • 波多黎各居民肺癌发病率较低,但宫颈癌、前列腺癌和结直肠癌发病率高于其他美国西班牙裔人群。

临床怎么用

  • 针对西班牙裔/拉丁裔人群独特的癌症谱,应加强感染预防与控制、健康饮食、体力活动和常规筛查。
  • 尤其应提高宫颈癌和结直肠癌筛查率,目前比白人低11个百分点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Hispanic/Latino population is the second largest racial and ethnic group in the United States, accounting for 20% of the total population (68 million), plus approximately 3 million Hispanic Americans residing in Puerto Rico. Herein, the American Cancer Society reports cancer occurrence, risk factors, and screening for US Hispanic people using federally funded, high-quality, population-based cancer registry data and national vital statistics and survey data. In 2026, an estimated 229,900 Hispanic people will be diagnosed with cancer, and 54,200 will die from the disease in the continental United States and Hawaii. Cancer incidence during 1998-2022 rose in Hispanic women (from 345 to 385 per 100,000) and fell in Hispanic men (from 471 to 389 per 100,000), narrowing the male-to-female incidence rate ratio from a peak of 1.40 (95% CI, 1.38-1.42) in 2002 to 1.01 (95% CI, 1.00-1.02; p = .02) in 2022. This pattern is partly driven by declining incidence of lung and prostate cancers among men and increasing incidence of breast and uterine corpus cancers among women. Although temporal trends mirror the general population, the Hispanic cancer distribution is distinct, consistent with relatively lower prevalence of smoking, alcohol drinking, and screening and higher prevalence of obesity and cancer-causing infections. Compared with White people, Hispanic people have one half the incidence of lung and urinary bladder cancers and 24% lower breast cancer but double the rate of liver, stomach, and gallbladder cancers, 61%-65% higher acute lymphocytic leukemia, and 36% higher cervical cancer. The cancer burden in Puerto Rico is distinct, with lower rates of lung cancer but higher rates of cervical, prostate, and colorectal cancers compared with other US Hispanic populations. Residents in Puerto Rico also experience lasting health care system challenges from extreme weather events. Thus, prevention efforts should target the unique cancer profile of the Hispanic population, including infection prevention and control, healthy eating, physical activity, and routine screening, especially for cervical and colorectal cancer that are 11 percentage points lower than White people.

来源:CA Cancer J Clin,查看原文。版权归原作者所有。

引用

  1. Saka AH, Kratzer TB, Giaquinto AN, et al. Cancer statistics for Hispanic/Latino people, 2026. CA Cancer J Clin. 2026. PMID: 42831778. doi:10.3322/caac.70107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。